These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22177238)

  • 1. [Gleason's grading of prostatic cancer: a current perspective].
    Cheng L; Wang X; Zhu YL; Zhang JM; Lopez-Beltran A; Montironi R
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):577-80. PubMed ID: 22177238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gleason's score in prostate adenocarcinoma and its application].
    Cao D
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):145-8. PubMed ID: 24842010
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
    Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with Gleason's histopathologic grading in prostatic cancer.
    Kramer SA; Spahr J; Brendler CB; Glenn JF; Paulson DF
    J Urol; 1980 Aug; 124(2):223-5. PubMed ID: 6995622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gleason's classification of prostatic adenocarcinomas].
    McNeal JE; Gleason DF
    Ann Pathol; 1991; 11(3):163-8. PubMed ID: 1878086
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on the Gleason grading system.
    Epstein JI
    Ann Pathol; 2011 Nov; 31(5 Suppl):S20-6. PubMed ID: 22054451
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gleason's score: update in 2008].
    Molinié V
    Ann Pathol; 2008 Oct; 28(5):350-3. PubMed ID: 19068389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 expression pattern in prostatic adenocarcinoma: Elucidation of differences between Gleason's grades.
    Kaur M; Verma S; Gupta R; Pant L; Singh S
    Malays J Pathol; 2018 Apr; 40(1):57-60. PubMed ID: 29704385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
    Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
    Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic carcinoma with emphasis on Gleason's Grading: an institution based experience.
    Ahmed Z; Muzaffar S
    J Pak Med Assoc; 2002 Feb; 52(2):54-6. PubMed ID: 12073709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.
    van der Kwast T
    Eur Urol; 2014 Jul; 66(1):174. PubMed ID: 24929078
    [No Abstract]   [Full Text] [Related]  

  • 12. Gleason's histologic grading as clinical prognostic marker in patients with advanced prostatic carcinoma.
    Schwartz CB; Bekirov H; Melman A
    Urology; 1991 Mar; 37(3):198-201. PubMed ID: 2000673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the prostate: reclaiming Gleason's sum].
    Espuela Orgaz R; Nogueras Gimeno MA; Passas Martínez J; Ruiz Liso JM; Sanz Anquela M
    Actas Urol Esp; 1982; 6(6):317-22. PubMed ID: 7183177
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reproducibility of malignancy grading in prostatic cancers using the Gleason-Böckling system].
    Kiss F; Lakner G; Csellár M; Nagy P; Tóth A; Vittay G
    Orv Hetil; 1997 May; 138(19):1195-9. PubMed ID: 9235527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gleason score 6 adenocarcinoma: should it be labeled as cancer?
    Carter HB; Partin AW; Walsh PC; Trock BJ; Veltri RW; Nelson WG; Coffey DS; Singer EA; Epstein JI
    J Clin Oncol; 2012 Dec; 30(35):4294-6. PubMed ID: 23032616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostate cancer histoseminar: Update of the 2016 WHO classification: Introduction].
    Ferlicot S
    Ann Pathol; 2017 Jun; 37(3):223. PubMed ID: 28522126
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological aggressiveness evaluation in prostate carcinomas:immunohistochemical analysis of PCNA and p53 in a series of Gleason 6 (3+3) adenocarcinomas.
    Cappello F; Palma A; Martorana A; Rappa F; Cabibi D; Barresi E; Melloni D; Farina F; Aragona F
    Eur J Histochem; 2003; 47(2):129-32. PubMed ID: 12777208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Grading: A Contemporary Photomontage.
    Epstein JI
    Am J Surg Pathol; 2016 Jan; 40(1):137. PubMed ID: 26658665
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histological classification of prostatic cancer].
    Sakamoto A; Terado Y
    Nihon Rinsho; 1998 Aug; 56(8):1959-62. PubMed ID: 9750487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.